Outlook Therapeutics, Inc. (OTLK)

Outlook Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	8.9	14.93	23.39	17.4	14.48	12.54
Cash & Short-Term Investments	8.9	14.93	23.39	17.4	14.48	12.54
Cash Growth	-72.21%	-36.19%	34.46%	20.17%	15.49%	56.40%
Accounts Receivable	1.75	-	-	-	-	-
Other Receivables	-	-	-	-	-	0.8
Receivables	1.75	-	-	-	-	0.8
Prepaid Expenses	6.32	12.49	7.59	10.12	7.03	4.61
Total Current Assets	21.1	27.42	30.98	27.52	21.51	17.94
Property, Plant & Equipment	0.24	0.27	0.03	0.07	0.28	0.49
Long-Term Investments	0.59	0.69	0.79	0.8	0.85	0.9
Long-Term Deferred Charges	0.31	0.33	-	0.12	-	-
Other Long-Term Assets	0.15	0.11	0.5	0.01	0.17	0.39
Total Assets	22.39	28.82	32.3	28.53	22.81	19.73
Accounts Payable	10.26	7.97	6.57	3.49	2.2	2.39
Accrued Expenses	5.31	3.24	2.75	3.43	1.73	3.79
Current Portion of Long-Term Debt	14	29.44	35.55	10.92	0.9	3.66
Current Portion of Leases	0.06	0.05	0	0.04	0.07	0.22
Current Income Taxes Payable	1.86	1.86	1.86	1.86	1.86	1.86
Other Current Liabilities	-	-	-	-	-	3.97
Total Current Liabilities	31.49	42.55	46.73	19.73	6.75	15.89
Long-Term Debt	20.44	-	-	-	10.89	0.9
Long-Term Leases	0.2	0.25	-	0	0.04	0.04
Other Long-Term Liabilities	7.45	59.1	0.01	0.06	0.52	0.07
Total Liabilities	59.58	101.9	46.74	19.79	18.2	16.91
Common Stock	0.43	0.24	0.13	2.27	1.76	1.27
Additional Paid-In Capital	554.79	469.97	453.35	415.4	345.73	291.27
Retained Earnings	-592.42	-543.28	-467.92	-408.94	-342.88	-289.72
Total Common Equity	-37.19	-73.08	-14.44	8.74	4.61	2.83
Shareholders' Equity	-37.19	-73.08	-14.44	8.74	4.61	2.83
Total Liabilities & Equity	22.39	28.82	32.3	28.53	22.81	19.73
Total Debt	34.7	29.74	35.56	10.96	11.9	4.83
Net Cash (Debt)	-25.8	-14.81	-12.16	6.44	2.57	7.71
Net Cash Growth	-	-	-	150.06%	-66.60%	-
Net Cash Per Share	-0.89	-0.80	-0.97	0.61	0.34	2.13
Filing Date Shares Outstanding	44.42	24.91	13.01	11.41	11.21	6.36
Total Common Shares Outstanding	43.48	23.91	13.01	11.37	8.82	6.36
Working Capital	-10.39	-15.14	-15.75	7.79	14.76	2.06
Book Value Per Share	-0.86	-3.06	-1.11	0.77	0.52	0.44
Tangible Book Value	-37.19	-73.08	-14.44	8.74	4.61	2.83
Tangible Book Value Per Share	-0.86	-3.06	-1.11	0.77	0.52	0.44
Machinery	-	-	-	-	1.07	1.07

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q